title: Serum level of 19-hydroxyandrostenedione during pregnancy and at delivery determined by gas chromatography/mass spectrometry.
abstract: 19-Hydroxyandrostenedione (19-OHA) is secreted from the adrenal glands in men and women and also from the placenta during pregnancy. It has been found to cause hypertension in animal models. We have synthesized [7,7-2H2]-19-OHA with high deuterium content and, together with [7,7-2H2]A and [9,11-2H2]estrone (E1), have developed a quantitative assay of serum level 19-OHA, A, and E1 using the gas chromatography/mass spectrometry-mass fragmentography method to monitor individual subjects throughout pregnancy. The labeled 19-OHA, used as internal standard, showed only 6.73% of unlabeled compound. Recovery of standard 19-OHA, A, and E1 (5,000 pg each) added to male plasma was 97.4 +/- 2.3%, 96.3 +/- 2.1%, and 100.1 +/- 4.1% (mean +/- SD), respectively; the intraassay coefficient of variation was 2.1%, 3.5%, and 3.8%, respectively. Ten pregnant subjects without complications and 10 pregnant subjects near term with hypertension were selected (with informed consent). The 19-OHA and E1 serum concentrations of maternal venous blood from uncomplicated pregnancies increased significantly as gestation progressed (19-OHA: first trimester, 225 +/- 72; second trimester, 656 +/- 325; third trimester, 1,518 +/- 544 pg/ml), reaching the highest level at delivery (19-OHA: 1,735 +/- 684 pg/ml). Whereas a positive correlation was found between the level of 19-OHA and E1, no apparent change of the A level was observed during pregnancy. Levels of the three steroid hormones in pregnancy complicated by hypertension in the second and third trimester were not found to be significantly different from those of normal pregnancy (19-OHA of hypertensive subjects: second trimester, 762 +/- 349; third trimester, 1,473 +/- 491 pg/ml).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Endocrine Biochemistry Department, Medical Foundation of Buffalo Research Institute, NY 14203.
authors.forename: Y
authors.initials: Y
authors.lastname: Osawa
authors.forename: S
authors.initials: S
authors.lastname: Ohnishi
authors.forename: C
authors.initials: C
authors.lastname: Yarborough
authors.forename: S
authors.initials: S
authors.lastname: Ohigashi
authors.forename: T
authors.initials: T
authors.lastname: Kosaki
authors.forename: M
authors.initials: M
authors.lastname: Hashino
authors.forename: T
authors.initials: T
authors.lastname: Yanaihara
authors.forename: T
authors.initials: T
authors.lastname: Nakayama
mesh_terms: D000735:Androstenedione / Q000031:analogs & derivatives* / Q000097:blood; D003903:Deuterium; D005260:Female; D005312:Fetal Blood / Q000032:analysis*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007743:Labor, Obstetric / Q000097:blood*; D008297:Male; D010920:Placenta / Q000032:analysis; D011247:Pregnancy / Q000097:blood*; D012015:Reference Standards; D013256:Steroids / Q000302:isolation & purification
chemical_list: D013256:Steroids; D000735:Androstenedione; C011482:19-hydroxy-4-androstene-3,17-dione; D003903:Deuterium